Related Experiment Video
Updated: Jul 19, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
[Serologic diagnosis of chlamydial and Mycoplasma pneumoniae infections]
B de Barbeyrac1, F Obeniche, E Ratsima
1Laboratoire de Bactériologie, Centre National de Référence des Infections à Chlamydia, Centre Hospitalier Universitaire, Bordeaux. Bertille.de.barbeyrac@u-bordeaux2.fr
Abstract:
The diagnosis of Chlamydia trachomatis infection can be based either on direct detection of the organism or its components or indirectly by measuring antibodies as markers of the individual's response to the infection. The latter is currently of limited value. Neither IgG or IgA antibodies can be used to diagnose current genital infection by Chlamydia trachomatis or to exclude such an infection. There is no solid ground as yet for the use of IgA antibodies as a marker of persistant or unresolved infection. Commercial tests in the Elisa format based on peptides from the MOMP of Chlamydia trachomatis are available and show good specificities and sensitivities. Hsp60 seems to have a unique role in the development of tubal scarring and antibodies to chsp60 could predict tubal factor infertility. Serology is the main diagnostic tool for the diagnosis of Mycoplasma pneumoniae infection. The serologic assays are the complement fixation test (CF), immunofluorescence, the microparticle agglutination and recently EIAs. The CF test is still used for serodiagnosis of Mycoplasma pneumoniae infection because of the sensitivity of 90%. Single titer of >or= 64 are considered to be indicative of recent infection. A number of commercial EIAs have been developped. The difficulty for IgG interpretation is a definition of a cutoff value for discriminating infected and healthy subjects. Most of the IgM assays show good diagnostic sensitivities and are valuable tools for the early diagnosis of Mycoplasma pneumoniae infection in children. There are no wholly satisfactory serological methods for diagnosis of Chlamydia pneumoniae infection. Problems arise from the high background of IgG antibody prevalence, the lack of standardized testing methods.
Insights
Serological tests for Chlamydia trachomatis and Chlamydia pneumoniae infections have limitations. While some Mycoplasma pneumoniae serological assays show promise, particularly IgM for early diagnosis in children, overall serodiagnosis requires further standardization.
Area of Science:
- Medical Microbiology
- Immunology
- Infectious Diseases
Background:
- Serological methods are crucial for diagnosing Chlamydia trachomatis, Mycoplasma pneumoniae, and Chlamydia pneumoniae infections.
- Current serological approaches for Chlamydia trachomatis have limitations in diagnosing active infections.
- Antibodies to heat shock protein 60 (hsp60) may predict tubal factor infertility.
Purpose of the Study:
- To evaluate the diagnostic utility of serological markers for Chlamydia trachomatis, Mycoplasma pneumoniae, and Chlamydia pneumoniae.
- To assess the reliability of different antibody types (IgG, IgA, IgM) in diagnosing these infections.
- To identify challenges and potential improvements in serological diagnostic methods.
Main Methods:
- Review of existing serological diagnostic techniques including ELISA, complement fixation (CF), and immunofluorescence.
- Analysis of antibody responses (IgG, IgA, IgM) to specific antigens like MOMP and hsp60.
- Evaluation of commercial assay performance and diagnostic criteria.
Main Results:
- IgG and IgA antibodies are of limited value for diagnosing current Chlamydia trachomatis genital infections.
- Commercial ELISA tests for Chlamydia trachomatis using MOMP peptides show good sensitivity and specificity.
- Complement fixation (CF) tests for Mycoplasma pneumoniae offer 90% sensitivity, with titers >= 64 indicating recent infection.
- IgM assays are valuable for early Mycoplasma pneumoniae diagnosis in children.
- Serodiagnosis of Chlamydia pneumoniae is challenging due to high IgG prevalence and lack of standardization.
Conclusions:
- Serological diagnosis of Chlamydia trachomatis requires further refinement, with limited utility for IgG and IgA in current infections.
- Antibodies to chsp60 may serve as a predictive marker for tubal factor infertility.
- While some serological assays for Mycoplasma pneumoniae are effective, particularly IgM for pediatric cases, standardization remains an issue for Chlamydia pneumoniae diagnosis.
Related Concept Videos
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Bacterial Phylum Chlamydiae